# REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

> **NCT05223413** · NA · RECRUITING · sponsor: **Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III** · enrollment: 608 (estimated)

## Conditions studied

- Anthracycline-induced Cardiac Toxicity
- Lymphoma

## Interventions

- **DEVICE:** RIPC
- **DEVICE:** Simulated RIPC (Sham)

## Key facts

- **NCT ID:** NCT05223413
- **Lead sponsor:** Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-18
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 608 (ESTIMATED)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05223413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05223413, "REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05223413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*